A comparison of post-COVID vaccine myocarditis classification using the Brighton Collaboration criteria versus Centre for Disease Control criteria

Commun Dis Intell (2018). 2023 Jan 19:47. doi: 10.33321/cdi.2023.47.2.

Authors

Tessa R Marshall¹, Silja Schrader¹, Laura Voss¹, Jim P Buttery^{1

2

3

4}, Nigel W Crawford^{1

2

3}, Daryl R Cheng^{1

2

3

4}

Affiliations

¹ SAEFVIC, Murdoch Children's Research Institute, Parkville.
² Royal Children's Hospital Melbourne, Parkville.
³ Department of Paediatrics, University of Melbourne, Parkville.
⁴ Centre for Health Analytics, Melbourne Children's Campus, Parkville.

PMID: 36654502
DOI: 10.33321/cdi.2023.47.2

No abstract available

MeSH terms

Australia / epidemiology
COVID-19 Vaccines
COVID-19* / epidemiology
COVID-19* / prevention & control
Centers for Disease Control and Prevention, U.S.
Humans
Myocarditis* / epidemiology
United States
Viral Vaccines*

Substances

COVID-19 Vaccines
Viral Vaccines